Add to ORKGDisclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors useful in predicting response to therapy and assessing risk of local-regional failure, survival and metastasis in cancer patients. Also disclosed are methods for characterizing tumors according to gene expression and kits for use in the methods of the invention
2noExploring prognostic and predictive response therapy factors in cancer disease is one of the most...
Analysis by DNA microarrays has led to the identification of molecular subtypes of breast carcinomas...
International audiencePredicting drug response is a challenging problem in oncology. In the 1975-198...
Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors ...
Embodiments of the invention are directed to methods of determining the prognosis of a breast cancer...
Numerous options are currently available for tumour typing. This has raised intense interest in the ...
The present invention relates to methods, kits and systems for the prognosis of the disease outcome ...
The elucidation of the human genome and advances in knowledge about molecular abnormalities, signali...
Abstract: Over the last 10 years there has been an explosion of information about the molecular biol...
Described are mathematical models and method, e.g., computer-implemented methods, for predicting tum...
The invention provides diagnostic and prognostic methods which comprise determining the level of exp...
Abstract. The elucidation of the human genome and advances in knowledge about molecular abnormalitie...
Over the last 10 years there has been an explosion of information about the molecular biology of can...
The invention provides a molecular marker set that can be used for prognosis of colorectal cancer in...
The present invention relates to gene sets, the expression levels of which are useful for classifyin...
2noExploring prognostic and predictive response therapy factors in cancer disease is one of the most...
Analysis by DNA microarrays has led to the identification of molecular subtypes of breast carcinomas...
International audiencePredicting drug response is a challenging problem in oncology. In the 1975-198...
Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors ...
Embodiments of the invention are directed to methods of determining the prognosis of a breast cancer...
Numerous options are currently available for tumour typing. This has raised intense interest in the ...
The present invention relates to methods, kits and systems for the prognosis of the disease outcome ...
The elucidation of the human genome and advances in knowledge about molecular abnormalities, signali...
Abstract: Over the last 10 years there has been an explosion of information about the molecular biol...
Described are mathematical models and method, e.g., computer-implemented methods, for predicting tum...
The invention provides diagnostic and prognostic methods which comprise determining the level of exp...
Abstract. The elucidation of the human genome and advances in knowledge about molecular abnormalitie...
Over the last 10 years there has been an explosion of information about the molecular biology of can...
The invention provides a molecular marker set that can be used for prognosis of colorectal cancer in...
The present invention relates to gene sets, the expression levels of which are useful for classifyin...
2noExploring prognostic and predictive response therapy factors in cancer disease is one of the most...
Analysis by DNA microarrays has led to the identification of molecular subtypes of breast carcinomas...
International audiencePredicting drug response is a challenging problem in oncology. In the 1975-198...